Praxis Precision Medicine...

NASDAQ: PRAX · Real-Time Price · USD
47.14
-0.56 (-1.17%)
At close: Aug 15, 2025, 3:59 PM
47.08
-0.13%
After-hours: Aug 15, 2025, 04:34 PM EDT

Praxis Precision Medicines Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
7.76M 8.12M 8.55M 1.6M 1.77M 2.19M 2.45M 1.93M 1.46M 683K n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
93K 154K 266K 330K 651K 856K 1.05M 1.24M 1.21M 1.21M 1.17M 1.43M 1.65M 1.66M 1.59M 1.03M 525K 206K
Gross Profit
7.67M 7.97M 8.29M 1.27M 1.12M 1.34M 1.4M 691K 252K -522K -1.17M -1.43M -1.65M -1.66M -1.59M -1.03M -525K -206K
Operating Income
-271.59M -233.01M -200.16M -164.01M -132.7M -130.17M -126.37M -140.02M -158.79M -184.23M -214.99M -232.19M -232.67M -208.76M -167.33M -134.39M -105.83M -80.92M
Interest Income
4.94M n/a n/a 928K 1.81M 2.46M 2.46M 1.53M 648K 200K 200K 200K 200K n/a 46K 52K 53K 58K
Pretax Income
-251.01M -212.56M -182.82M -151.02M -123.74M -125.38M -123.28M -137.57M -156.88M -182.77M -214.03M -231.44M -232.2M -208.41M -167.06M -134.18M -105.7M -80.86M
Net Income
-251.01M -212.56M -182.82M -151.02M -123.74M -125.38M -122.64M -136.66M -155.62M -181.31M -213.07M -230.76M -231.87M -208.27M -167.06M -134.19M -105.7M -80.86M
Selling & General & Admin
57.32M 54.89M 56.3M 51.11M 44.58M 44.12M 42.05M 45.24M 50.37M 57.02M 59.95M 61.97M 59.75M 53.78M 47.08M 41.37M 33.17M 24.88M
Research & Development
221.98M 186.24M 152.41M 114.51M 89.89M 88.25M 86.77M 96.71M 109.89M 127.89M 155.04M 170.22M 172.92M 154.98M 120.26M 93.02M 72.67M 56.04M
Other Expenses
n/a n/a n/a n/a 884K 884K 884K 1.16M 625K 825K 957K 747K 475K 357K 225K 155K 82K 5K
Operating Expenses
279.31M 241.13M 208.72M 165.62M 134.47M 132.36M 128.82M 141.95M 160.26M 184.91M 214.99M 232.19M 232.67M 208.76M 167.33M 134.39M 105.83M 80.92M
Interest Expense
n/a n/a n/a 106K 106K 106K 106K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
279.35M 241.13M 208.72M 165.62M 134.47M 132.36M 128.82M 141.95M 160.26M 184.91M 214.99M 232.19M 232.67M 208.76M 167.33M 134.39M 105.83M 80.92M
Income Tax Expense
n/a -107K -219K -219K -328K -237.09K -761.09K -1.04M -1.28M -1.46M -957K -682K -332K -424K -475K -462K -467K -172K
Shares Outstanding (Basic)
21.47M 21.06M 19.98M 18.88M 18.82M 13.9M 9.06M 9.04M 4.65M 3.54M 3.17M 3.05M 3.04M 3.03M 3M 2.98M 2.77M 2.56M
Shares Outstanding (Diluted)
21.47M 21.06M 19.98M 18.88M 18.82M 13.9M 9.06M 9.04M 4.65M 3.54M 3.17M 3.05M 3.04M 3.03M 3M 2.98M 2.77M 2.56M
EPS (Basic)
-12.29 -10.72 -10.27 -10.3 -10.27 -15.91 -23.47 -33.39 -44.96 -57.34 -69.57 -76.22 -76.93 -70.3 -58.34 -51.36 -182.37 -274.88
EPS (Diluted)
-12.29 -10.72 -10.27 -10.3 -10.27 -15.91 -23.47 -33.39 -44.96 -57.34 -69.57 -76.22 -76.93 -70.3 -58.34 -51.36 -182.37 -274.88
EBITDA
-266.41M -232.71M -199.81M -163.59M -132.26M -129.73M -125.94M -139.59M -158.38M -183.91M -214.69M -231.9M -232.45M -208.51M -167.15M -134.28M -105.75M -80.86M
EBIT
-266.65M -233.01M -200.16M -164.01M -132.7M -130.17M -126.37M -140.02M -158.79M -184.23M -214.99M -232.19M -232.67M -208.76M -167.33M -134.39M -105.83M -80.92M
Depreciation & Amortization
232K 293K 358K 422K 651K 856K 1.05M 1.24M 1.21M 1.21M 1.17M 1.43M 1.65M 1.66M 1.59M 1.05M 555K 246K